External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
Romain DiamandKarsten GuenzelTeddy JabbourArthur BaudewynsHenri-Alexandre BourgenoYolène LefebvreMariaconsiglia FerrieroGiuseppe SimoneAlexandre FourcadeGeorges FournierAlexandre Patrick BuiFayek TahaMarco OderdaPaolo GonteroKaterina RysankovaAdrian Bernal-GomezAlessandro MastrorosaJean-Baptiste RocheGaelle FiardRawad Abou ZahrGuillaume PloussardOlivier WindischQuentin NovelloDaniel BenamranGina DelavarJulien AnractNicolas Barry DelongchampsAdam HalinskiCharles DarianeLéonidas VlahopoulosGregoire AssenmacherThierry RoumeguèreAlexandre PeltierPublished in: World journal of urology (2024)
We report a comprehensive external validation of risk prediction models for csPCa diagnosis in patients who underwent MRI-targeted and systematic biopsies. The model by Alberts demonstrated superior clinical utility and should be favored when determining the need for a prostate biopsy.